Table 4 Association between individual SNPs and MM OS, adjusted by stage (Durie-Salmon).
From: Genetically determined telomere length and multiple myeloma risk and outcome
SNP | Gene | Allele | MAFa | EAa | Allelic modelb | Codominant modelc | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
M/m | HRa | 95% CIa | Pvalue | HRHet | 95% CI | Pvalue | HRHom | 95% CI | Pvalue | ||||
rs11125529 | ACYP2 | C/A | 0.11 | A | 0.90 | 0.71–1.13 | 0.369 | 0.89 | 0.68–1.16 | 0.391 | 0.59 | 0.37–1.93 | 0.710 |
rs6772228 | PXK | T/A | 0.04 | T | 1.30 | 0.89–1.89 | 0.165 | 1.18 | 0.78–1.75 | 0.426 | 4.51 | 1.06–19.17 | 0.041 |
rs10936599 | TERC | C/T | 0.24 | C | 1.20 | 1.00–1.43 | 0.048 | 1.23 | 0.98–1.54 | 0.066 | 1.34 | 0.80– 2.23 | 0.265 |
rs7675998 | NAF1 | G/A | 0.24 | G | 1.18 | 0.98–1.42 | 0.080 | 1.11 | 0.88–1.40 | 0.374 | 1.62 | 0.99–2.63 | 0.053 |
rs2736100 | TERT | A/C | 0.50 | C | 1.05 | 0.89–1.22 | 0.536 | 1.02 | 0.77–1.34 | 0.879 | 1.10 | 0.70–1.49 | 0.545 |
rs9420907 | OBFC1 | A/C | 0.13 | C | 0.96 | 0.78–1.17 | 0.724 | 0.95 | 0.75–1.20 | 0.690 | 0.95 | 0.51–1.85 | 0.941 |
rs3027234 | CTC1 | C/T | 0.22 | C | 1.03 | 0.86–1.23 | 0.726 | 1.00 | 0.79–1.25 | 0.993 | 1.15 | 0.71–1.83 | 0.559 |
rs8105767 | ZNF208 | A/G | 0.28 | G | 1.01 | 0.85–1.19 | 0.913 | 1.06 | 0.84–1.32 | 0.612 | 0.95 | 0.62–1.42 | 0.799 |
rs412658 | ZNF676 | C/T | 0.35 | T | 0.98 | 0.83–1.15 | 0.847 | 1.01 | 0.80–0.25 | 0.943 | 0.95 | 0.66–1.35 | 0.763 |
rs6028466 | DHX35 | G/A | 0.07 | A | 1.15 | 0.86–1.52 | 0.350 | 1.10 | 0.78–1.54 | 0.562 | 1.58 | 0.58–4.27 | 0.369 |
rs755017 | ZBTB46 | A/G | 0.12 | G | 0.86 | 0.67–1.09 | 0.216 | 0.92 | 0.70–1.20 | 0.559 | 0.44 | 0.14–1.37 | 0.158 |